Cancer cells travel through the bloodstream looking for places to take root. Yet one spot they almost never conquer is the heart — the pump that carries them all over the body.
A new study offers a striking explanation. The heart may resist tumors because it never truly rests: constant contraction and stretching send physical signals to cancer cells that put the brakes on growth genes, turning cardiac muscle into a hostile environment for tumors.
The work is still early and relies heavily on mouse models and engineered tissues, but it opens an unusual possibility: future anti‑cancer approaches might borrow from the heartbeat.
How experiments showed the heart fights tumors
The study, led by Giulio Ciucci and Serena Zaccignia at the International Centre for Genetic Engineering and Biotechnology in Trieste, Italy, began with a biological hint: shortly after birth, mammalian heart cells almost stop dividing. This loss of regenerative ability makes recovery after severe heart injury or heart failure much harder.
The authors asked whether the same forces that halt division of adult cardiomyocytes might also suppress growth of cancer cells in the heart.
In an initial experiment, the team used genetically engineered mice in which cancer‑promoting mutations could be activated in several organs — the liver, the heart, and skeletal muscles. Tumors formed in various parts of the body, but the heart stayed free of growths.
Next the team ran a more direct test: they created an extra heart in mice by transplanting one into the neck and connecting it to the circulation. The transplanted heart was alive and received blood, but it wasn’t doing the main work of pumping blood through the whole body — its mechanical load had been removed.
When the researchers injected cancer cells into both hearts, the cells quickly expanded in the “unloaded” transplanted hearts. By contrast, cancer cells struggled to establish themselves in the animals’ own hearts, which continued beating under normal pressure.
The same pattern showed up in lab‑grown cardiac tissues: when normal mechanical load was present, tumor growth slowed, and when the load was removed, lung, colon, and melanoma cancer cells grew more easily.
How mechanical forces reach the cell nucleus
The study also revealed a possible pathway by which the heartbeat’s force affects a cancer cell internally. A key player is the protein Nesprin‑1, which helps connect a cell’s outer structure to its nucleus, where DNA is stored. Nesprin‑1 is one mechanism by which a cell senses pressure, stretch, or movement.
Under normal pulsatile load from the heart, Nesprin‑1 activity increased. Cancer cells altered how they handled their chromatin: instead of remaining in a state favorable to replication, their DNA‑packaging and regulatory systems switched into a different mode.
DNA in a cell is packed and unpacked as needed, like thread on a spool. With the heart’s pulsing, those epigenetic mechanisms appeared to change: the researchers observed shifts in chemical marks that determine whether growth genes stay “silent” or turn on.
In rare cases of metastases to the human heart, the authors found similar signs of altered DNA packaging — the overall pattern was similar across tumors from different origins. That strengthens the idea that the heartbeat does more than press on cells from the outside; it really alters their genetic regulation.
Turn off the “brakes” and tumors grow
To test whether Nesprin‑1 was truly important, the researchers disabled this protein in lung cancer cells before implanting them into mouse hearts.
The result was clear: without Nesprin‑1, the cancer cells were able to grow even under normal mechanical load. They formed large tumors in beating hearts that would normally repel them.
This suggests that the heart doesn’t just batter tumors with motion — its mechanical force appears to activate a molecular brake inside the cancer cells themselves. If that brake is switched off, the cells start growing even in conditions where they normally wouldn’t establish themselves.
“Our results show that the heart’s pulsation is not only a physiological function but also a natural suppressor of tumor growth,” Serena Zaccignia said in a statement. “That means the cardiac environment is hostile to cancer cells not only for immunological or metabolic reasons, but also because its continuous mechanical activity physically limits their expansion.”
Could we treat tumors with a “massage”?
Most of the work so far was done in mice, in transplanted hearts, and in engineered tissues. In humans, tumors grow in a far more complex environment — surrounded by immune cells, different blood vessels, scar tissue, and chemical signals.
Still, the results have pushed the authors toward a bold experiment: applying rhythmic mechanical stimulation to tumors outside the heart.
Zaccignia’s team is working with engineers on devices that could sit on the skin and press on surface tumors, for example, certain forms of skin or breast cancer.
“We already have the first prototypes, and the results are encouraging,” Zaccignia told STAT. “Beyond adding mechanical stimulus, this is a kind of ‘massage’ for the tumor that could potentially improve delivery of chemo‑ or immunotherapy.”
But that approach will need careful testing: researchers must determine which tumors respond to mechanical action, what pressure and frequency are effective, and whether mechanical stimulation could cause unwanted effects. Cancer cells are very different from one another, and a force that restrains one tumor type might barely affect another.
For now, the discovery adds another layer to how we understand the heart: its constant movement can shape cell behavior and make life much harder for cancer cells in that organ. The results were published in the journal Science, but the authors and commentators emphasize that more research is needed before ideas about “rhythmic therapy” can move into clinical practice.
Based on reporting by ZME Science
